Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Commitment will complement crucial decarbonization efforts to help reduce near-term warming DUBAI, United Arab Emirates, Dec. 2, 2023 /PRNewswire/ -- Today at COP28, leading climate philanthropies...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
On November 30th, the 28th session of the Conference of the Parties (COP28) to the United Nations Framework Convention on Climate Change (UNFCCC) convened in Dubai, United Arab Emirates. On the...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Jackson State University officially introduced Marcus L. Thompson, Ph.D., as its 13th president during a press conference held on his fourth day in office, Nov. 30. Thompson addressed the media...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
M.D.C. Holdings, Inc. (NYSE: MDC) announced that it is scheduled to present at the Raymond James TMT and Consumer Conference on Tuesday, December 5, 2023, at 2:15 p.m. ET. The presentation can be...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Groundbreaking data unveiled in San Antonio: CLIA validated genTRU-breast assay achieves >99% sensitivity in stage I breast cancer NEWPORT BEACH, Calif., Dec. 1, 2023 /PRNewswire/ -- Mammogen, a...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Leading global solutions provider showcases new product support for Oracle cloud backup and recovery operations and achieves AWS Level 1 MSSP Competency MONTREAL, Dec. 1, 2023 /PRNewswire/ --...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
New analyses from phase 3, long-term, open-label, repeat-dose study of VALTOCO® (diazepam nasal spray) CIV will be presented Additional presentations explore anticipatory anxiety of seizures,...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that Hyung Heon Kim, President and...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that...